These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2810722)

  • 21. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis.
    Dajani AS; Kessler SL; Mendelson R; Uden DL; Todd WM
    Pediatr Infect Dis J; 1993 Apr; 12(4):275-9. PubMed ID: 8483620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
    Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C
    Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study Group.
    Brown RJ; Batts DH; Hughes GS; Greenwald CA
    Clin Ther; 1991; 13(5):579-88. PubMed ID: 1799915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections].
    Li JT; Hou J; Kao L
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials of cefpodoxime proxetil suspension in paediatrics.
    Fujii R
    Drugs; 1991; 42 Suppl 3():57-60. PubMed ID: 1726209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
    Muranaka H; Yokoyama M
    J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
    Terui T; Tagami H
    J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
    Imanaka H; Kitahara T; Yoshinaga M; Miyata K
    J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
    [No Abstract]   [Full Text] [Related]  

  • 31. Cefpodoxime proxetil.
    Del Beccaro MA
    Pediatr Ann; 1993 Mar; 22(3):187-92, 195-6. PubMed ID: 8464650
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical studies of cefpodoxime proxetil in respiratory tract infections].
    Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Takahashi H; Numata H; Takahashi K; Yamaki I; Ishii S
    Jpn J Antibiot; 1988 Oct; 41(10):1538-44. PubMed ID: 3204658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefpodoxime proxetil: a new, broad-spectrum, oral cephalosporin.
    Chocas EC; Paap CM; Godley PJ
    Ann Pharmacother; 1993 Nov; 27(11):1369-77. PubMed ID: 8286813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of rokitamycin dry syrup in pediatrics].
    Minamitani M; Hachimori K; Kaneda K
    Jpn J Antibiot; 1988 Jul; 41(7):863-70. PubMed ID: 3172459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical observations on cefuzonam in pediatrics].
    Sekiguchi T; Okamoto T; Ohara K; Miyauchi Y; Nishioka A; Kawahito S; Saijo T
    Jpn J Antibiot; 1987 Mar; 40(3):671-9. PubMed ID: 3613086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
    Safran C
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetic and clinical studies on SY5555 dry syrup in children].
    Harada Y; Matsumoto T; Tsuji Y; Gondou I; Kobayashi N; Hayashi K; Uchida T; Uehara Y; Kido T; Fukuda T
    Jpn J Antibiot; 1995 Feb; 48(2):261-70. PubMed ID: 7745815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients].
    Toyonaga Y; Ishihara T; Nakamura H
    Jpn J Antibiot; 1996 Nov; 49(11):981-93. PubMed ID: 8988410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil.
    Dajani AS
    Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S7-11. PubMed ID: 7792129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.